VUJOSEVIC, STELA
 Distribuzione geografica
Continente #
NA - Nord America 4.439
EU - Europa 405
AS - Asia 341
AF - Africa 7
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.198
Nazione #
US - Stati Uniti d'America 4.433
CN - Cina 183
SG - Singapore 129
IT - Italia 94
FI - Finlandia 93
SE - Svezia 83
DE - Germania 35
GB - Regno Unito 31
FR - Francia 27
UA - Ucraina 19
IN - India 12
IE - Irlanda 9
CA - Canada 6
EG - Egitto 6
HK - Hong Kong 4
KR - Corea 4
AU - Australia 3
NL - Olanda 3
ES - Italia 2
EU - Europa 2
JP - Giappone 2
OM - Oman 2
PL - Polonia 2
RU - Federazione Russa 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
IL - Israele 1
JO - Giordania 1
LT - Lituania 1
ME - Montenegro 1
MY - Malesia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
SC - Seychelles 1
Totale 5.198
Città #
Fairfield 770
Woodbridge 507
Houston 429
Ann Arbor 389
Ashburn 293
Chandler 290
Cambridge 289
Seattle 265
Wilmington 248
Jacksonville 103
Boardman 101
Singapore 91
San Diego 88
Princeton 81
Medford 54
Des Moines 52
Padova 45
Beijing 44
Helsinki 34
Nanjing 29
Roxbury 26
Santa Clara 24
Guangzhou 14
Nanchang 11
Dearborn 9
New York 9
Shenyang 9
Dublin 8
Hebei 8
Jiaxing 7
Phoenix 7
Cagliari 6
Cairo 6
Hefei 6
London 6
Norwalk 6
Changsha 5
Falls Church 5
Indiana 5
Lexington 5
Redwood City 5
Iksan 4
Kharkiv 4
Orange 4
Rome 4
Atlanta 3
Catania 3
Hounslow 3
Jinan 3
Kunming 3
Montreal 3
Ningbo 3
Central 2
Chiswick 2
Columbus 2
Dallas 2
Hong Kong 2
Ibri 2
Islington 2
Maserà di Padova 2
Milan 2
Naples 2
Ogden 2
Pudasjärvi 2
Pune 2
Sant'angelo Romano 2
Sydney 2
Tappahannock 2
Tianjin 2
Valencia 2
Zhengzhou 2
Arklow 1
Bergamo 1
Borås 1
Brampton 1
Brisbane 1
Brookline 1
Buffalo 1
Changchun 1
Chengdu 1
Chongqing 1
Falkenstein 1
Jakarta 1
Kilburn 1
Kuala Lumpur 1
Lanzhou 1
Lappeenranta 1
Ludwigshafen am Rhein 1
Manila 1
Miami Beach 1
Moscow 1
Musselburgh 1
Müswangen 1
New Bedfont 1
New Delhi 1
Niksic 1
Osaka 1
Otawara 1
Ottawa 1
Polska 1
Totale 4.493
Nome #
Diabetic macular edema: Correlation between microperimetry and optical coherence tomography findings 160
In vivo monosomy 3 detection of posterior uveal melanoma: 3-year follow-up 132
Aqueous Humor Biomarkers of Müller Cell Activation in Diabetic Eyes. 132
Scanning laser ophthalmoscopy in the retromode in diabetic macular oedema 116
One-Year Progression of Diabetic Subclinical Macular Edema in Eyes with Mild Nonproliferative Diabetic Retinopathy: Location of the Increase in Retinal Thickness 115
Confocal scanning laser ophthalmoscope in the retromode imaging modality in exudative age-related macular degeneration. 112
Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration 110
In vivo detection of monosomy 3 in eyes with medium-sized uveal melanoma using transscleral fine needle aspiration biopsy 109
Combined grading for choroidal neovascularisation: colour, fluorescein angiography and autofluorescence images. 109
Normal Values for Fundus Perimetry with the Microperimeter MP1 108
Retinal function in patients with serpiginous choroiditis: a microperimetry study 107
Diabetic Macular Edema: Fundus Autofluorescence and Functional Correlations 105
Long-term choroidal vascular changes after iodine brachytherapy versus transpupillary thermotherapy for choroidal melanoma. 104
Subthreshold laser therapy for diabetic macular edema: metabolic and safety issues. 104
Static and dynamic retinal fixation stability in microperimetry 103
HYPERREFLECTIVE RETINAL SPOTS AND VISUAL FUNCTION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CENTER-INVOLVING DIABETIC MACULAR EDEMA. 102
Retinal Layer Location of Increased Retinal Thickness in Eyes with Subclinical and Clinical Macular Edema in Diabetes Type 2 101
Macular and peripapillary choroidal thickness in diabetic patients. 100
Microperimetry: Technical remarks 99
Diabetes and retinal vascular disorders 97
Characterization of retinal disease progression in a 1-year longitudinal study of eyes with mild nonproliferative retinopathy in diabetes type 2 97
Detection of macular function changes in early (AREDS 2) and intermediate (AREDS 3) age-related macular degeneration 94
Visual psychophysics in Diabetic Retinopathy 93
Retinal fixation impairment in diabetic macular edema 92
HYPERREFLECTIVE RETINAL SPOTS AND VISUAL FUNCTION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN CENTER-INVOLVING DIABETIC MACULAR EDEMA 89
HYPERREFLECTIVE INTRARETINAL SPOTS IN RADIATION MACULAR EDEMA ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY 87
Neuroretinal activation in diabetes mellitus 87
Retinal Layers Changes in Human Preclinical and Early Clinical Diabetic Retinopathy Support Early Retinal Neuronal and Müller Cells Alterations 86
Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. 86
The Nonmydriatic Fundus Camera in Diabetic Retinopathy Screening: A Cost-Effective Study with Evaluation for Future Large-Scale Application. 84
A decade-long telemedicine screening program for diabetic retinopathy in the north-east of Italy 83
Imaging retinal inflammatory biomarkers after intravitreal steroid and anti-VEGF treatment in diabetic macular oedema 82
Diabetic Retinopathy in Italy: Epidemiology Data and Telemedicine Screening Programs 81
Microperimetry and fundus autofluorescence in diabetic macular edema subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation. 78
Diagnosing and monitoring diabetic macular edema: structural and functional tests. 78
Relevance of Retinal Thickness Changes in the OCT Inner and Outer Rings to Predict Progression to Clinical Macular Edema: An Attempt of Composite Grading of Macular Edema 78
Stage 1 Type 3 Neovascularization With Choroidal Dilation Unresponsive to Anti-VEGF Treatment 78
Wavefront-optimized surface ablation with the Allegretto Wave Eye-Q exicmer laser platform: 12 month visual and refractive results. 77
Fundus autofluorescence and microperimetry in progressing geographic atrophy secondary to age-related macular degeneration. 77
EXTENT OF DIABETIC MACULAR EDEMA BY SCANNING LASER OPHTHALMOSCOPE IN THE RETROMODE AND ITS FUNCTIONAL CORRELATIONS 77
Spontaneous Active Bleeding From Normal-Appearing Iris Margin 74
Rod function in diabetic patients without and with early diabetic retinopathy 73
Long-term longitudinal modifications in mesopic microperimetry in early and intermediate age-related macular degeneration 73
Aqueous humor biomarkers of müller cell activation in diabetic eyes 73
Photodynamic therapy for iris metastasis from a mediastinal carcinoid tumor 70
Microperimetry in diabetic retinopathy 69
Single retinal layer changes after subthreshold micropulse yellow laser in diabetic macular edema 69
Diabetic Macular Edema With and Without Subfoveal Neuroretinal Detachment: Two Different Morphologic and Functional Entities 67
Metamorphopsia: An Overlooked Visual Symptom 64
Diabetic Retinopathy. 62
Controversies in pharmacological treatment of inflammatory component of macular edema 62
Terson syndrome associated with acute macular neuropathy type 2 62
Short wavelenght fundus autofluorescence versus near-infrared fundus autofluorescence, with microperimetric correspondance, in patients with geographic atrophy due to age-related macular degeneration 60
Hyperreflective Intraretinal Spots in Diabetics without and with Nonproliferative Diabetic Retinopathy: An In Vivo Study Using Spectral Domain OCT 55
The Decreasing Prevalence of Nonrefractive Visual Impairment in Older Europeans: A Meta-analysis of Published and Unpublished Data 54
Autofluorescence Imaging in Age-Related Macular Degeneration Complicated by Choroidal Neovascularization. A Prospective Study 49
Hyperreflective intraretinal spots in diabetics without and with nonproliferative diabetic retinopathy: An in vivo study using spectral domain OCT 49
Diabetic Retinopathy Screening Using an Expert System with an Operator-Free Nidek Orion Fundus Camera 47
HYPERREFLECTIVE RETINAL SPOTS IN NORMAL AND DIABETIC EYES: B-Scan and En Face Spectral Domain Optical Coherence Tomography Evaluation 46
Associations with intraocular pressure across Europe: The European Eye Epidemiology (E3) Consortium 41
Pegylated interferon-associated retinopathy is frequent in HCV patients with hypertension and justifies ophthalmologic screening. 38
SUBTHRESHOLD MICROPULSE YELLOW LASER VERSUS SUBTHRESHOLD MICROPULSE INFRARED LASER IN CENTER-INVOLVING DIABETIC MACULAR EDEMA: Morphologic and Functional Safety. 33
Microperimeter MP1 Reply 31
CHANGES OF AQUEOUS HUMOR MÜLLER CELLS' BIOMARKERS IN HUMAN PATIENTS AFFECTED BY DIABETIC MACULAR EDEMA AFTER SUBTHRESHOLD MICROPULSE LASER TREATMENT 31
Investigational use of an automated diabetic retinopathy screening with an artificially-intelligent, non mydriatic, operator-free fundus camera. 27
Fundus Autofluorescence in Diabetic Retinopathy 25
Standardization of Optical Coherence Tomography Angiography Imaging Biomarkers in Diabetic Retinal Disease 21
Totale 5.334
Categoria #
all - tutte 20.115
article - articoli 18.517
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.063
Totale 39.695


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020701 0 0 0 0 116 85 103 113 100 62 71 51
2020/2021805 34 70 17 109 32 114 41 64 135 55 93 41
2021/2022980 32 144 157 69 44 39 66 94 34 17 104 180
2022/2023621 124 66 8 77 118 75 4 31 80 6 18 14
2023/2024235 16 31 24 28 14 15 11 17 3 7 37 32
2024/2025312 6 81 52 55 118 0 0 0 0 0 0 0
Totale 5.334